Search

Champions Oncology Inc

Slēgts

SektorsVeselības aprūpe

4.99 -0.8

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.91

Max

5.15

Galvenie mērījumi

By Trading Economics

Ienākumi

-389K

-667K

Pārdošana

-2.7M

14M

P/E

Sektora vidējais

35.118

57.002

EPS

-0.05

Peļņas marža

-4.821

Darbinieki

214

EBITDA

-278K

-174K

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 11. sept.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-13M

71M

Iepriekšējā atvēršanas cena

5.79

Iepriekšējā slēgšanas cena

4.99

Ziņu noskaņojums

By Acuity

50%

50%

171 / 340 Rangs Healthcare

Champions Oncology Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. aug. 19:26 UTC

Champions Oncology Inc shares are higher during Thursday's session, rebounding from an earlier dip despite remaining below the 20-day moving average.

2026. g. 12. aug. 19:51 UTC

Champions Oncology Inc's shares are lower today, diverging from recent gains, with no specific news identified to explain the decline.

2026. g. 11. aug. 19:41 UTC

Champions Oncology Inc shares are lower today amid no specific news. The stock remains below its 20-day moving average and near the month's low.

2026. g. 10. aug. 19:31 UTC

Champions Oncology Inc shares are lower, continuing a decline since Friday's close. The stock remains near its one-month range's lower end.

2026. g. 7. aug. 19:42 UTC

Champions Oncology Inc shares are higher, driven by gains in the Life Sciences Tools & Services sub-sector. Earlier, they pulled back from a session high.

2026. g. 6. aug. 19:32 UTC

Champions Oncology Inc shares are lower, continuing a downward trend amid broader market concerns over inflation and Federal Reserve policy. No specific news was identified.

2026. g. 5. aug. 19:31 UTC

Champions Oncology Inc shares are lower during Wednesday's session, reflecting significant volatility amid broader market conditions and a notable drop in crude oil prices.

2026. g. 4. aug. 19:51 UTC

Champions Oncology Inc shares are lower today, influenced by a decline in the Life Sciences Tools & Services sub-sector. The stock remains below its 20-day moving average.

2026. g. 3. aug. 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

2026. g. 31. jūl. 19:46 UTC

Champions Oncology Inc shares are higher today, reflecting a positive move since Thursday's close, though still below the 20-day moving average.

2026. g. 30. jūl. 17:16 UTC

Champions Oncology is trading lower today, continuing a trend of declines over the past three sessions, despite positive broader market sentiment.

2026. g. 29. jūl. 19:02 UTC

Champions Oncology Inc is trading higher during Wednesday's session, breaking from its recent upward trend. Broader market dynamics are influenced by rising oil prices.

2026. g. 28. jūl. 19:32 UTC

Champions Oncology Inc. shares are trading lower amid broader market declines, particularly in technology sectors across Asia, with no specific company news identified.

2026. g. 27. jūl. 23:01 UTC

News

Champions Oncology shares declined in after-market trading following mixed fourth-quarter earnings, despite adjusted EPS of $0.01 and record annual revenue of $59.4 million.

2026. g. 24. jūl. 20:06 UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

2026. g. 22. jūl. 19:41 UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Salīdzinājums

Cenas izmaiņa

Champions Oncology Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

171 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat